Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Rezular – Oral Treatment for IBS

AGI Therapeutics is developing a range of drugs to treat a variety of common GI diseases and disorders, including IBS, functional dyspepsia, ulcerative colitis and gastro-esophageal reflux disease (GERD).



Go Top